Investigating the impact of type 2 diabetes mellitus on brain function in obstructive sleep apnea patients using...

This study aims to investigate the effects of Type 2 Diabetes Mellitus (T2DM) on brain function in patients with Obstructive Sleep Apnea (OSA) using Regional Homogeneity (ReHo) combined with seed-based Functional Connectivity (FC) methods.

46 OSA patients, 38 OSA with T2DM patients, and 34 healthy controls (HC) were prospectively recruited. Clinical data were collected from all participants, and neuropsychological testing was performed using the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Epworth Sleepiness Scale (ESS). Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected, and ReHo combined with seed-based FC analysis was used to assess brain function differences among the three groups. Finally, partial correlation analysis was conducted to investigate the relationship between clinical variables and imaging metrics ofthe differential brain regions.

Compared to HCs group, the OSA group showed increased ReHo in the left occipital gyrus, and decreased ReHo in the right fusiform gyrus and left cerebellum region 8. Furthermore, FC between the left occipital gyrus and left cerebellum region 8, as well as between the right fusiform gyrus and left cerebellum region 3, was significantly decreased. Partial correlation analysis revealed a significant negative correlation between ReHo in the right fusiform gyrus and the Oxygen Desaturation Index (ODI), and a significant positive correlation between FC in the left cerebellum region 8 and MMSE scores. Compared to the OSA group, the OSA with T2DM group exhibited decreased ReHo in the left occipital gyrus, with increased FC between the left occipital gyrus and left thalamus. Partial correlation analysis showed that ReHo in the left occipital gyrus was significantly negatively correlated with the Insulin Resistance Index (IRI), while FC in the left thalamus was negatively correlated with MoCA scores and positively correlated with hemoglobinA1c (HbA1c) levels.

T2DM affects brain function in OSA patients, further exacerbating cognitive burden. These findings provide valuable insights into the neuropathological mechanisms ofT2DM in OSA and support the development of objective neuroimaging biomarkers.